| Millennium Initiates Cardiovascular Collaboration with The Cleveland Clinic |
Abstract
pdf
|
|
Business Review Editor |
|
| Cell Therapeutics Researches Oncology Targets with Hope Heart Institute |
Abstract
pdf
|
|
Business Review Editor |
|
| CeNeS Licenses MS Treatment to Acorda |
Abstract
pdf
|
|
Business Review Editor |
|
| Roche Secured Option on Antisoma Pipeline |
Abstract
pdf
|
|
Business Review Editor |
|
| AlphaRx to License Anticancer Toxin from Select Therapeutics |
Abstract
pdf
|
|
Business Review Editor |
|
| Allergan Licenses Phase I Skin Cancer Drug from Peplin |
Abstract
pdf
|
|
Business Review Editor |
|
| Roche’s Option on Antisoma |
Abstract
|
|
Business Review Editor |
|
| Deal Making in the Drug Delivery Sector |
Abstract
|
|
Business Review Editor |
|
| Technology Focus: PEGylation |
Abstract
|
|
Business Review Editor |
|
| Lundbeck Strengthens CNS Research Through Acquisition of Synaptic |
Abstract
pdf
|
|
Business Review Editor |
|
| Senetek Enters into Two Agreements in its Core Areas of Erectile Dysfunction and Skin Care |
Abstract
pdf
|
|
Business Review Editor |
|
| LG Life Sciences to Market Thymitaq® in Republic of Korea |
Abstract
pdf
|
|
Business Review Editor |
|
